This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Zhonghao Chenguang Research Institute of Chemical Industry Company Limited, Other. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 834,513 Years Active: 2012-2016
Title: Xianyong Liu: Innovator in Immunology and Vaccine Development
Introduction
Xianyong Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. With a total of 2 patents, Liu's work focuses on enhancing immune responses through novel approaches.
Latest Patents
Liu's latest patents include the development of a porcine CD28 receptor and its application. This invention provides a porcine CD28 receptor molecule, which is a protein consisting of an amino acid sequence represented by SEQ ID NO:2. The receptor can also be derived from this sequence through substitutions, deletions, or additions of amino acids while maintaining equivalent activity. Additionally, Liu has developed a gene for encoding the porcine CD28 receptor, with its nucleotide sequence shown as SEQ ID NO:1. This innovation enhances T cell activation, proliferation, and cytokine secretion when stimulated by an antigen, thereby improving the acquired immune response and vaccine efficacy.
Another significant patent involves the use of coccidian as a vaccine live vector. This invention presents a live vaccine utilizing transgenic coccidian capable of expressing exogenous proteins. The coccidian vector live vaccine can induce protective humoral and cellular immune responses, including mucosal immunity, while ensuring high biological safety and stability without generating immune tolerance.
Career Highlights
Throughout his career, Xianyong Liu has worked with notable organizations, including the Zhonghao Chenguang Research Institute of Chemical Industry Company Limited. His expertise in immunology and vaccine development has positioned him as a key figure in advancing vaccine technologies.
Collaborations
Liu has collaborated with esteemed colleagues such as Xun Suo and Xiaojia Wang. These partnerships have contributed to the success of his innovative projects and patents.
Conclusion
Xianyong Liu's contributions to immunology and vaccine development are noteworthy. His innovative patents reflect his commitment to enhancing immune responses and improving vaccine efficacy. Liu's work continues to influence the field and pave the way for future advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile